GoKawiilCancer care startup Thyme Care raises $125M, valuation tops $2 billion
Thyme Care, a virtual navigation platform for cancer patients, closed a $125 million Series E round led by Morgan Health with Humana and CVS Health Ventures participating, doubling its valuation to over $2 billion in less than a year. The company is also creating a new parent entity, Thyme Companies, to launch additional businesses tackling gaps in cancer care delivery, access and payment, with co-founder Robin Shah as executive chairman.
GoKawiil's interpretation of the reporting above, not reported fact.
The rapid valuation jump signals strong investor confidence in tech-driven approaches to fixing fragmented, costly cancer care, especially with backing from major insurers and pharmacy players like Humana and CVS. With services reaching 10.5 million people and managing over $7 billion in oncology spend, Thyme Care's expansion could reshape how cancer treatment coordination is funded and delivered nationally.
- Thyme Care's $125M Series E round doubles its valuation to over $2 billion in under a year.
- The startup is forming a new parent company, Thyme Companies, to expand beyond navigation into other cancer care gaps.
- Revenue grew fivefold last year, and the platform now serves over 10.5 million people managing $7 billion in oncology spend.
Mom's Medical History Medical Organizer Binder — Navigating a cancer diagnosis means juggling test results, appointment notes, insurance paperwork and medication lists — exactly the fragmentation Thyme Care's navigation platform aims to smooth out. A dedicated medical organizer binder with tabbed sections keeps every document in one place for appointments and second opinions. It's a simple, low-tech companion for patients and caregivers coordinating complex care.
See Mom's Medical History Medical Organizer Binder on Amazon → Affiliate link — we may earn a commission on purchases, at no extra cost to you. Product picked by AI based on this article; it is not a tested recommendation.Source: cnbc.com — Ian Thomas, 2026-09-02
Published there as: “Thyme Care raises $125 million, pushing cancer care startup's valuation above $2 billion”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.